Drugs.com - FDA MedWatch Alerts

Main Products, Inc. Issues Recall of Umary Acido Hialuronico, Suplemento Alimenticio Due to the Presence of Undeclared Drug Ingredients

Audience: Consumer, Health Professional, Pharmacy, Pain Management, Gastroenterology July 22, 2024 – Chula Vista, CA – Main Products, Inc. is voluntarily recalling all lots of “Umary Acido Hialuronico, Suplemento...

Feb 9, 2025 - 21:45
 0
Main Products, Inc. Issues Recall of Umary Acido Hialuronico, Suplemento Alimenticio Due to the Presence of Undeclared Drug Ingredients
Audience: Consumer, Health Professional, Pharmacy, Pain Management, Gastroenterology July 22, 2024 – Chula Vista, CA – Main Products, Inc. is voluntarily recalling all lots of “Umary Acido Hialuronico, Suplemento...
Read More

Tags:

Previous Article

FDA Warns Against Purchasing or Using Chemical Peel Skin Products Without Profes...

Next Article

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of...

Related Posts

Endo USA, Inc. Issues Recall of One Lot of Clonazepam Orally Disintegrating Tablets Due to Mislabeling: Incorrect Strength on Product Carton

Endo USA, Inc. Issues Recall of One Lot of Clonazepam O...

Feb 9, 2025  0

Boulla LLC Issues Voluntary Nationwide Recall of Boom Max Capsules Due to the Potential Presence of Undeclared Sildenafil

Boulla LLC Issues Voluntary Nationwide Recall of Boom M...

Feb 9, 2025  0

One Source Nutrition, Inc. Issues Voluntary Nationwide Recall of Vitality Capsules Due to Presence of Undeclared Sildenafil and Tadalafil

One Source Nutrition, Inc. Issues Voluntary Nationwide ...

Feb 23, 2025  0